Nordic Capital Fund V ("Nordic Capital") and funds advised by CVC Capital Partners ("CVC") have through their holding companies Cidron Pord S.A.R.L and Godis Holding S.A.R.L, on 28 November 2012, agreed to sell 21 million shares on a pro rata basis in Cloetta AB ("Cloetta" or the "Company") to four institutional investors, representing 7.3% of all outstanding shares in the Company. Lannebo Fonder AB, one of Sweden's leading equity fund managers, acquired 16.5 million shares, representing 5.7% of all outstanding shares in the Company. The price paid by investors was SEK 13.25 per share. Following the closing of the sale, Nordic Capital will own 61,336,079 shares representing 21.3% of capital and 15.5% of votes in Cloetta and CVC will own 82,525,559 shares representing 28.6% of capital and 20.9% of votes in Cloetta.
The trade was arranged by Carnegie Investment Bank.
Grupo GSH’S next stage of growth backed by leading global investor CVC
Mehiläinen agrees the acquisitions of Regina Maria and MediGroup and welcomes Hellman & Friedman as a new shareholder alongside CVC
CVC, Nordic Capital and ADIA complete acquisition of Hargreaves Lansdown to accelerate and enhance its transformation plan and deliver on its growth potential
Multiply Group signs landmark investment with CVC and PAI Partners to secure a controlling stake (67.91%) in Tendam, with the transaction expected to double Multiply’s operational EBITDA post-consolidation
PureHealth agrees to acquire Majority Stake in Hellenic Healthcare Group from funds managed by CVC Capital Partners and Management in EUR 2.2 Billion Transaction